Tag: Plus
Quantum Physics Plus Writing Equals World Peace
by Internet Archive Book Images The Age of Aquarius has given us the most powerful paradigm ever offered to mankind as a gift of the Creator God. This paradigm is the Laws of Quantum Physics. There have been a few individuals down though the ages who have understood the Laws of Quantum Physics and the […]
Poly-Control To Offer First Smart Locks Certified for Z-Wave Plus
AARHUS, Denmark and HANNOVER, Germany (PRWEB) March 16, 2015 Z-Wave Plus Offers Greater Battery Life, Longer RF Range, Faster Operation, Easier Installation and More; See at CeBIT 2015 With the growing demand for more advanced featured and better designed smart home technology, Poly-Control, a provider of innovative smart technology solutions for homes and businesses, […]
Tutorial: Rocket Science! (plus special announcement)
[youtube http://www.youtube.com/watch?v=XwaGW-x7hS0&fs=1&rel=0] The basic physics behind how rockets work! (plus a special announcement) Perimeter Institute: http://www.pitp.ca VomitPhysics video: http://www.youtube.com/w… [youtube http://www.youtube.com/watch?v=7rMgpExA4kM&fs=1&rel=0] Behind-the-Scenes of an Airbus A350 being built! Thanks to the folks at Airbus for bringing me to France, Germany, & the UK to visit their headquarters and f… Video Rating: 4 / 5
Top Florida Lice Removal Company Expands to Second Lice Clinic Plus In-Home Service
Miami, FL (PRWEB) December 23, 2014 Lice Troopers, the all-natural head lice removal service, prepares to launch its second clinic with the New Year. Already a household name in the south Florida area, the Coral Gables treatment center will provide a convenient location for families and schools in the area, including Sunset, Key Biscayne, Brickell, […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]